Join to View Full Profile
505 Parnassus AveSan Francisco, CA 94143
Phone+1 415-476-1528
Dr. Upadhyay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vaibhav Upadhyay is an Assistant Professor in Pulmonary and Critical Care at UCSF. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine. He specializes in critical care medicine. He is a physician scientist whose published works can be viewed here: https://www.ncbi.nlm.nih.gov/myncbi/1vKTAkd3asb5k/bibliography/public/
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2018 - 2021- University of California (San Francisco)Residency, Internal Medicine, 2015 - 2018
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2015
Certifications & Licensure
CA State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity.Kai R Trepka, Wesley A Kidder, Than S Kyaw, Taylor Halsey, Christine A Olson
Science Translational Medicine. 2025-04-16 - 2 citationsPharma[e]cology: How the Gut Microbiome Contributes to Variations in Drug Response.Kai R Trepka, Christine A Olson, Vaibhav Upadhyay, Chen Zhang, Peter J Turnbaugh
Annual Review of Pharmacology and Toxicology. 2025-01-01 - 7 citationsA diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity.Margaret Alexander, Vaibhav Upadhyay, Rachel Rock, Lorenzo Ramirez, Kai Trepka
Cell Reports. 2024-11-26
Press Mentions
CDC Rates Pfizer Vaccine 66% on Efficacy Scale Against Delta VariantOctober 4th, 2021- How COVID-19 Variants Could Outsmart VaccinesSeptember 28th, 2021
Grant Support
- Impact of gut bacterial metabolites on lung function and diseaseUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
- Impact of gut bacterial metabolites on lung function and diseaseUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
